Verition Fund Management LLC Clovis Oncology, Inc. Transaction History

Verition Fund Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$4.06 - $5.8 $158,011 - $225,730	-38,919 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$5.02 - $7.05 $195,373 - $274,378	38,919 New	38,919 $226,000
Q2 2019 Aug 14, 2019	SELL	$12.81 - $25.67 $103,376 - $207,156	-8,070 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$17.66 - $30.28 $142,516 - $244,359	8,070 New	8,070 $200,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.